Teva, Allergan reach $161.5 million opioid settlement with West Virginia
Reuters
Published May 25, 2022 09:47AM ET
Updated May 25, 2022 10:51AM ET
By Dietrich Knauth
(Reuters) -Teva Pharmaceutical Industries and AbbVie (NYSE:ABBV)'s Allergan (NYSE:AGN) unit reached a settlement worth $161.5 million to resolve claims the companies fueled an opioid epidemic in West Virginia, state attorney general Patrick Morrisey said Wednesday.
The agreement is the largest state-negotiated settlement in West Virginia history, and consists of $134 million in cash plus the contribution of drugs used to treat opioid overdoses, Morrisey said.
"This is a great day for West Virginia," Morrisey said at a press conference.
The settlement ended a trial that had been proceeding for two months in Kanawha County Circuit Court. The companies did not admit wrongdoing in making the settlement.
Teva said it will pay $83 million in cash, as well as a 10-year supply of Narcan, a drug used to stop opioid overdoses, which the state valued at $27 million. Allergan could not immediately be reached for comment.
The settlement includes a "most favored nation" clause which will protect West Virginia during the two companies' efforts to reach a nationwide settlement of opioid claims, Morrisey said. West Virginia will receive at least 2.25% of the two companies' future nationwide settlement number.
West Virginia previously reached a $99 million settlement with Johnson & Johnson (NYSE:JNJ) and a $26 million settlement with Endo International (NASDAQ:ENDP) Plc. Endo settled before the trial began and J&J settled two weeks into the trial.
Israel-based Teva has said that it expects a deal by the end of the year. The company believes it will have to pay around $2.6 billion in cash and medicine to reach a nationwide settlement.
Teva reached opioid settlements with Texas and Rhode Island earlier this year.
West Virginia has been hit particularly hard by opioid abuse and overdoses, with more than three times the national rate of overdose deaths in 2020, according to the U.S. Centers for Disease Control & Prevention.
West Virginia had accused Teva and Allergan of deceiving prescribers about the risks of opioid painkillers when marketing their drugs for the treatment for chronic pain. The misleading marketing led to an increase in substance abuse and overdose deaths, according to West Virginia's complaint.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.